Development of the icure system for crchd provided by MDB INC:1108559 [19-061852]
Ended Awarded
- Contract number
- 75N91019F00132
- Awardee
-
Mdb, Inc. UEI J4KLUDGBKYJ7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $137,540
Award facts
- Contract value 100% obligated
- $137,540.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20036, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a $137.5K firm fixed-price BPA call contract to MDB Inc. (doing business as Michael D. Baker Inc.) for the development of the iCure System for CRCHD. The contract was awarded on September 3, 2019, with an ultimate completion date of September 8, 2020, and performed in Washington, D.C. This award was made under the Professional Services Schedule (PSS) without a small business set-aside designation.
MDB Inc., a small business federal contractor based in Washington, D.C., specializes in delivering professional services across research support, technical communication, and administrative consulting domains. The company maintains established relationships with multiple federal agencies including the National Institutes of Health and the National Institute of Environmental Health Sciences, and holds several significant Indefinite Delivery Vehicles and Blanket Purchase Agreements totaling over $25 million. This iCure System development contract represents a task order execution within the company's existing BPA framework with the National Cancer Institute.
Quick answers
Who was awarded contract 75N91019F00132?
75N91019F00132 was awarded to Mdb, Inc. by National Cancer Institute (National Institutes of Health) on September 3, 2019.
How much is contract 75N91019F00132 worth?
The government has obligated $137,540 on 75N91019F00132.
Is contract 75N91019F00132 an order under another contract?
Yes. 75N91019F00132 is a BPA call under GS00F0001S-HHSN263201000141B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75N91019F00132 competed?
The extent of competition for 75N91019F00132 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award